Dr. Stephen Smith Kennedy, MD, FACP Internal Medicine - Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 1108 Doe Mountain Rd, Goodview, VA 24095 Phone: 540-890-5347 |
News Archive
Seattle Genetics, Inc. (NASDAQ:SGEN), announced today that it has achieved a milestone under its antibody-drug conjugate (ADC) collaboration agreement with MedImmune, LLC, a wholly owned subsidiary of AstraZeneca. The milestone was triggered by MedImmune's initiation of a phase I clinical trial of MEDI-547, its anti-EphA2 ADC for solid tumors.
An investigational drug to treat Type 2 diabetes, empagliflozin, lowers blood pressure in patients with Type 2 diabetes and hypertension (high blood pressure), a new study finds. The results were presented Sunday in a late-breaking abstract at the joint meeting of the International Society of Endocrinology and The Endocrine Society: ICE/ENDO 2014 in Chicago.
Spectral images, which contain more color information than is obtainable with a typical camera, reveal characteristics of tissue and other biological samples that can't be seen by the naked eye.
Men undergoing active surveillance for prostate cancer have very low rates - one percent or less - of cancer spread (metastases) or death from prostate cancer, according to a recent study published in The Journal of Urology®, an Official Journal of the American Urological Association.
› Verified 2 days ago